Recently, several signature genes have been associated with poor prognosis in CML, including IGFBP2, SRSF11, BAX, CDKN1B, BNIP3L, FZD7, PRSS57, and MRPS2845,46. This evidence concerns the gene SRSF11 and chronic myelogenous leukemia, BCR-ABL1 positive.